Alcon AG Total Liabilities

Latest as of December 2025: CHF9.51 Billion CHF ≈ $12.03 Billion USD

Alcon AG total liabilities. Based on the latest financial reports, Alcon AG (ALC) has total liabilities worth CHF9.51 Billion CHF (≈ $12.03 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Alcon AG's assets to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Alcon AG (2015–2025)

Total liabilities of Alcon AG from 2015 to 2025. This chart illustrates how Alcon AG's total liabilities have evolved over time, based on quarterly financial data. Explore Alcon AG (ALC) investment intensity to see how much of total assets are deployed in long-term investments.

Alcon AG Competitors by Total Liabilities

The table below lists competitors of Alcon AG ranked by their total liabilities.

Company Country Total Liabilities
STMicroelectronics NV ADR
NYSE:STM
USA $6.96 Billion
Ameren Corp
NYSE:AEE
USA $37.40 Billion
Shinhan Financial Group Co Ltd
NYSE:SHG
USA $755.24 Trillion
KONE Oyj
HE:KNEBV
Finland €6.23 Billion
Prudential plc
F:PRU2
Germany €203.06 Billion
Everpure, Inc.
NYSE:P
USA $3.31 Billion
Orsted A/S
CO:ORSTED
Denmark Dkr187.69 Billion
Iron Mountain Incorporated
NYSE:IRM
USA $21.24 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Alcon AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Alcon AG.

Liquidity & Leverage Metrics

Alcon AG Total Liabilities Ratios Explained

Alcon AG total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.12 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.43 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.30 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Alcon AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Alcon AG (2015–2025)

The table below shows the annual total liabilities of Alcon AG from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 CHF9.51 Billion
≈ $12.03 Billion
+8.18%
2024-12-31 CHF8.79 Billion
≈ $11.12 Billion
-2.18%
2023-12-31 CHF8.99 Billion
≈ $11.37 Billion
-5.69%
2022-12-31 CHF9.53 Billion
≈ $12.05 Billion
+9.02%
2021-12-31 CHF8.74 Billion
≈ $11.05 Billion
-0.40%
2020-12-31 CHF8.78 Billion
≈ $11.10 Billion
+5.10%
2019-12-31 CHF8.35 Billion
≈ $10.56 Billion
+7.27%
2018-12-31 CHF7.79 Billion
≈ $9.84 Billion
+78.62%
2017-12-31 CHF4.36 Billion
≈ $5.51 Billion
-7.80%
2016-12-31 CHF4.73 Billion
≈ $5.98 Billion
+3.57%
2015-12-31 CHF4.57 Billion
≈ $5.77 Billion
--

About Alcon AG

SW:ALC Switzerland Medical Instruments & Supplies
Market Cap
$38.13 Billion
CHF30.16 Billion CHF
Market Cap Rank
#880 Global
#15 in Switzerland
Share Price
CHF61.88
Change (1 day)
+1.08%
52-Week Range
CHF48.75 - CHF67.06
All Time High
CHF84.68
About

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other product… Read more